SCHEMBL8995714

SCHEMBL8995714

CCc1nc(C(=O)O)c(C(=O)O)c(CC)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.41
DPP4 P27487 3/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
ADORA3 P0DMS8 3/20 0.36
KDM4E B2RXH2 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9784571 0.85 HCAR2 (0.41) HCAR2DPP4DPP8DPP9ADORA3
SCHEMBL8995696 0.85 GABRP (0.37) HCAR2DPP4DPP8DPP9ADORA3
SCHEMBL9784563 0.79 HCAR2 (0.38) HCAR2DPP4DPP8DPP9ADORA3
SCHEMBL29188835 0.79 GABRP (0.33) HCAR2DPP4DPP8DPP9ADORA3
SCHEMBL31436370 0.78 HCAR2 (0.41) HCAR2DPP4DPP8DPP9ADORA3
SCHEMBL8995682 0.76 KMO (0.34) HCAR2DPP4DPP8DPP9ADORA3
SCHEMBL30968740 0.76 HCAR2 (0.33) HCAR2DPP4DPP8DPP9ADORA3
SCHEMBL11375262 0.75 ALDH1A1 (0.40) HCAR2DPP4DPP8DPP9ADORA3
SCHEMBL8977153 0.75 KDM4E (0.38) HCAR2KDM4EGAA
SCHEMBL29774205 0.74 TDP1 (0.39) HCAR2MEN1KMT2ANPC1FABP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118480002-A High-selectivity synthesis method of imazamox intermediate diethyl 5-bromomethyl-2, 3-pyridine dicarboxylic acid 湖北三峡实验室 2024-08-13 CN claimed
EP-0461403-B1 Process for the preparation of dialkyl pyridine-2,3-dicarboxylate and derivatives thereof from dialkyl dichlorosucciante AMERICAN CYANAMID CO (US) 1996-08-28 EP claimed
CN-222076592-U Acidification kettle for producing 5-methyl-pyridine-2, 3-dicarboxylic acid diethyl ester 苏州嘉实稳博新能源有限公司 2024-11-29 CN disclosed
CN-118480002-A High-selectivity synthesis method of imazamox intermediate diethyl 5-bromomethyl-2, 3-pyridine dicarboxylic acid 湖北三峡实验室 2024-08-13 CN disclosed
CN-221385246-U Rectifying device for producing 5-methyl-pyridine-2, 3-diethyl dicarboxylate 武威昌鸿科技有限公司 2024-07-23 CN disclosed
CN-220939170-U Rectifying device for production and processing of 5-methyl-pyridine-2, 3-dicarboxylic acid diethyl ester 武威昌鸿科技有限公司 2024-05-14 CN disclosed
EP-4001266-A2 PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE Adama Agan Ltd. (IL) 2022-05-25 EP disclosed
US-10669254-B2 Process for preparing methoxy methyl pyridine dicarboxylate ADAMA AGAN LTD. (IL) 2020-06-02 US disclosed
EP-3541787-A1 PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE Adama Agan Ltd. (IL) 2019-09-25 EP disclosed
US-20190276427-A1 PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE ADAMA AGAN LTD. (IL) 2019-09-12 US disclosed
WO-2018091964-A1 PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE ADAMA AGAN LTD. (IL) 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10669254-B2 Process for preparing methoxy methyl pyridine dicarboxylate MCCC2, C5, KDM4C HCAR2 612/4885DPP4 1363/4885DPP8 3961/4885
US-20190276427-A1 PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE MCCC2, C5, KDM4C HCAR2 612/4885DPP4 1363/4885DPP8 3961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.